Samer Shukur Mohammed

@ruc.edu.iq

faculty of Pharmacy
Al-Rafidain university college

Samer Shukur Mohammed

EDUCATION

Bachelor in Pharmaceutical sciences since 2007 from College of Pharmacy-University of Baghdad
Master of Science in Pharmacology since 2014 from College of Medicine-University of Baghdad
PhD in Pharmacology since 2022 from College of medicine-University of Nahrain

RESEARCH INTERESTS

Pharmacology
15

Scopus Publications

83

Scholar Citations

4

Scholar h-index

3

Scholar i10-index

Scopus Publications

  • Bacterial Community Diversity, Richness, and Possible Immunotherapies Association in Response to Spray-Dried Porcine Plasma-Fed Diet: An Animal Model
    Pirmatova Alina, Imad Ghanem Qasim, Sura Akram Mohammed, Samer Shukur Mohammed, Waleed Nassar, et al.
    Trends in Immunotherapy, 2025
    This study aims to demonstrate the significance of employing non-invasive dietary intervention to control the diversity and abundance of bacterial communities in feces. The indexing databases Scopus, PubMed/Medline, ISI Web of Science, Embase, Cochrane Central, and CINAHL were extensively searched. Only 13 of 541 papers found in the initial searches met the criteria. Seven studies involving 210 animals were included in this meta-analysis. The SDPP group showed statistically lower Shannon (SMD: 1.20, 95% CI: 0.22–2.19, I2: 88%, p = 0.02) and Chao1 (SMD: 2.95, 95% CI: 1.99–3.91, I2: 77%, p < 0.00001) indices than the control group. The SDPP-diet fed group showed notably lower OTU counts compared to the control group (SMD: 2.99, 95% CI: 0.67–5.32, I2: 97%, p = 0.01). The Firmicutes/Bacteroidetes ratio is reliably increased following the SDPP-fed diet (SMD: 0.68, 95% CI: 0.13–1.23, I2: 0%, p = 0.02). While noticeable differences existed between studies and difficulties were encountered in replicating basic ecological measurements, the purpose of this analysis was to identify the consistent characteristics of the gut microbiota's response to the SDPP diet, thereby pinpointing specific areas for further mechanistic research.
  • Development and Assessment of a Self-Nanoemulsifying Drug Delivery System Containing Bilastine: An Effective Strategy to Improve Dissolution
    Ishraq Kadhim Abbas, Alaa Abdulelah Abdulqader, Ahmed Abbas Hussein, Saba Abdulhadi Jaber, Samer Shukur Mohammed
    Al Rafidain Journal of Medical Sciences, 2025
    Background: Innovative approaches, including self-nanoemulsifying drug delivery systems, have the potential to solve a variety of drug formulation challenges, such as solubility, stability, and bioavailability. The drug candidate in this research is the strong and extremely selective H1-antihistamine, bilastine, that belongs to BCS II with low solubility and high permeability. Objective: This research aims to formulate an oral self-nanoemulsion of bilastine to improve dissolution. Methods: A total of fifteen liquid self-nanoemulsion drug delivery systems (SNEDDS) formulas were developed using oleic acid, cremophor, and Transcutol as the appropriate oils, stabilizers, and co-stabilizers based on the solubility studies of bilastine in various oils, stabilizers, and co-stabilizers. We used pseudoternary phase diagrams to look at the behavior of the component phases and the area of the nanoemulsion. The physicochemical properties of the formulas, in addition to thermodynamic stability, droplet size, polydispersity index, zeta potential, self-emulsification time, drug content, and durability of the developed formulations, were assessed. Results: This study demonstrated that formula 5, with a 20% oleic acid, 27% cremophor, and 53% Transcutol composition, had lower globular size, acceptable drug content, better in-vitro drug release, and ex-vivo permeability characteristics than pure bilastine powder. Conclusions: The mentioned factors all point to the preparation of self-nanoemulsifying drug delivery systems as a potential means for improving the dissolution of poorly soluble drugs like bilastine.
  • Immunotherapy in Patients with Allergic Asthma and Chronic Allergic Rhinitis: A Retrospective Cohort
    Seitova Aziza, Ahmed Mahdi Jassim, Sura Akram Mohammed, Samer Shukur Mohammed, Waleed Nassar, et al.
    Trends in Immunotherapy, 2025
    Asthma and allergies both cause similar signs and symptoms and often occur together. Evidence for the effectiveness of immunotherapy has rapidly increased in recent years. Several well-designed studies have demonstrated that allergen immunotherapy may prevent the development of asthma in people with allergic rhinitis. The present study aimed to assess the effect of subcutaneous immunotherapy with specific allergens on clinical symptoms, immunological factors, and cytokines in patients with allergic rhinitis and allergic asthma from the Kyrgyz Republic. This retrospective cohort study was conducted on patients with a slight to moderate level of persistent asthma and moderate to severe allergic rhinitis who had been referred to Osh State Clinic in Osh city, Kyrgyz Republic, from March 2000 to February 2025. About 160 atopic patients with allergic rhinitis and asthma were included in the study; confirmed by history, physical examination, and SPT, irrespective of gender. In patients with allergic asthma, 23 (58.97%) patients showed complete symptom improvement, 11 (28.2%) patients showed complete improvement, and 5 (12.82%) patients showed no response to treatment. Compared to previous treatment in the allergic rhinitis group, the cytokine TGFβ was significantly increased (p < 0.001), while the levels of IFN-γ (p = 0.047) and FOXP3 (p = 0.013) were also insignificantly decreased after immunotherapy. This study examined the impact of standard subcutaneous immunotherapy on patients with allergic respiratory diseases. The study also shows that immunotherapy stands as the most effective treatment for asthma and nasal allergies in patients who meet selection criteria, especially when medications do not work.
  • The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities’ regulations
    Samer Shukur Mohammed
    International Journal of Risk and Safety in Medicine, 2025
    Background Nutrivigilance has become increasingly vital as global supplement consumption rises. However, in many Middle Eastern countries, these products are marketed with limited oversight and minimal integration within existing pharmacovigilance systems. Objective To highlight the public health importance of nutrivigilance, review international models, and propose the incorporation of nutrivigilance practices into pharmacovigilance regulations within Middle Eastern health authorities. Methods This perspective synthesizes findings from global regulatory frameworks, including the U.S. FDA, European Food Safety Authority (EFSA), and national nutrivigilance programs and evaluates their applicability in Middle Eastern contexts. Results Significant variability exists between countries regarding nutrivigilance implementation. Developed nations employ structured post-marketing surveillance systems, whereas Middle Eastern countries lack harmonized approaches. The absence of specialized nutrivigilance units and public awareness campaigns contributes to underreporting and potential adverse health outcomes. Integrating nutrivigilance into national pharmacovigilance programs could enhance consumer safety, regulatory decision-making, and data sharing. Conclusion Establishing nutrivigilance within Middle Eastern pharmacovigilance regulations is an urgent public health priority. Creating dedicated departments, harmonizing standards, fostering regional collaboration, and enhancing reporting culture will strengthen safety monitoring and consumer protection.
  • Screening of FDA-approved Drugs against Protein Thymidine Kinase 2 Using Machine Learning Method Validated Applying Molecular Dynamics and Free Energy Landscape Calculation
    Hayder Naji Sameer, Samer Shukur Mohammed, Amjad Ibrahim Oraibi, Mahmood Al-Ibadah, Hany Aqeel Al-Hussainy
    Letters in Drug Design and Discovery, 2024
    Background: Thymidine kinase 2 (TK2) is a crucial enzyme in the mitochondrial pyrimidine salvage pathway, strongly associated with several mitochondrial diseases. Current treatments frequently damage mitochondria, leading to a decrease in cellular energy output. Objective: This study aimed to use computational approaches to identify inhibitors of TK2 that could prevent these harmful consequences. Methods: The initial screening process entailed the application of machine learning algorithms, more particularly a Random Forest model, which was trained on 189 FDA-approved drugs and decoy datasets obtained from the DUD-E database. Its purpose was to identify potential inhibitors. The molecular docking technique was employed to evaluate the affinity of the chosen medicines towards TK2. Molecular dynamics (MD) simulations lasting 100 nanoseconds were employed to conduct additional validation by examining the dynamic interactions between the top-found compounds and TK2. Results: Three hit compounds (3168, 5209502, and 135402009) were identified through the screening process for their high affinity for TK2. Compound 5209502 had the most stable interaction with the lowest root-mean-square deviation (RMSD) in the molecular dynamics (MD) simulations and maintained 12 hydrogen bonds consistently. MM/GBSA computations verified that 5209502 exhibited the strongest binding affinity with a binding free energy of -62.14 kcal/mol, which was notably lower than that of the control ligand. Conclusion: Compound 5209502 is a promising candidate for additional experimental evaluation because of its notable stability and great affinity for TK2. This chemical may provide a focused and less harmful treatment for mitochondrial illnesses linked to TK2 malfunction.
  • Effects of Lycopene as Monotherapy or Combined with Clobetasol on Spleen Index and Inflammatory Markers in Mouse Model of Imiquimod-Induced Psoriasis
    Samer Shukur Mohammed, Wael Waleed Mustafa
    Al Rafidain Journal of Medical Sciences, 2023
    Background: Lycopene has demonstrated favorable impacts on diverse health conditions, particularly those of an inflammatory nature. Objective: To evaluate the impact of topical application of lycopene on the spleens of mice with psoriasis induced by imiquimod (IMQ). Methods: The study employed a sample size of 48 mice, divided into six groups of eight mice each. The experimental protocol involved the application of IMQ to each of the five groups twice. The first application was administered for six days to induce psoriasis, followed by a second application for another six days while the tested medications were concurrently administered, with the exception of the first group, which served as the control group. Following the six-day induction phase, group 2 was treated exclusively with petrolatum jelly. On the other hand, groups 3-6 were subjected to different treatments, including clobetasol propionate, lycopene at concentrations of 0.125 mg/ml and 0.25 mg/ml, and a combination of 0.05% clobetasol and 0.25 mg/ml of lycopene. Each of the examined pharmaceutical substances was administered topically once daily for a duration of six days at the IMQ application site. Results: Lycopene at a concentration of 0.25 mg/ml resulted in a significant reduction in the spleen index and a restoration of the tissue levels of inflammatory mediators (TNF-α, IL-23, NF-κB, and IL-17) that were close to normal. Conclusion: The anti-inflammatory properties of lycopene can significantly aid in the normalization of spleens in patients who have developed psoriasis due to imiquimod.matory capabilities.
  • Anti-inflammatory Effects of Topically Applied Azilsartan in a Mouse Model of Imiquimod-induced Psoriasis
    International Journal of Drug Delivery Technology, 2022
  • Prevalence of Dietary Supplements Use among College Students in Iraq
    Wael Waleed Mustafa, Samer Shukur Mohammed, Muntader Mahdi Salih, Zahraa Taha Muhsin, Rasha Mohammed Muhsin
    Al Rafidain Journal of Medical Sciences, 2022
    Background: Dietary supplements (DS) are products that are intended to be consumed orally and serve the purpose of supplementing one's diet. Although, these products are very popular, their usage among undergraduate students in Iraq is still obscure. Aim: To evaluate the pattern, type, and reasons for supplement usage among Iraqi undergraduate students and to detect the source of information about dietary supplements. Methods: A sample of 442 students at different colleges in Baghdad were surveyed through a questionnaire composed of 13 questions and divided into four sections: socio-demographic, dietary supplement (DS) knowledge, DS intake, and reasons behind their usage. Descriptive statistics were conducted to determine the frequency and percentages of respondents for each variable. Results: A total of 442 participants were included in the study; 160 (36.2%) were males and 282 (63.8%) were females. Out of the total number of the participants, 329 (74%) were dietary supplement users, 139 (42.25%) were males, and 190 (57.75%) were females. Most of the participants (72%) used vit. D3 supplement, and the mean reason for using DS was to overcome nutritional deficiency. Conclusion: Most of the participants are dietary supplement users, with a higher percentage of females. The main reasons for both genders' resorting to dietary supplement use are to improve their health and improve their immunity.
  • Consequences of Restricting Tramadol Dispensing in Iraqi Private Healthcare Facilities
    Samer Shukur Mohammed, Wael Waleed Mustafa, Manal Mohammed Younis
    Al Rafidain Journal of Medical Sciences, 2022
    Background and aim: Tramadol is a codeine analogue with less analgesic power than morphine but with better abuse potential. However, chronic use is associated with different adverse effects like anxiety, euphoria, nervousness, insomnia, depression, and agitation. In this study, we assessed the outcome behind the restriction on dispensing Tramadol in private health sectors in Iraq. Methods: We look at tramadol data from VigiBase data searches and the Individual Case Safety Reports (ICSR) that are formally supported by the WHO worldwide database. All complaints were evaluated using Vigilyze data mining and computing IC25 to assess the strength of the link between Tramadol and the adverse reactions it causes, as well as to compare them to other records from around the world. Results: For patients who used tramadol in a variety of dose forms, 184 instances were gathered over the course of seven years by the Iraqi Pharmacovigilance Center. There were 32 cases of hyperhidrosis, which occurred when tramadol was used alone, 47 incidents of vomiting, and 67 cases of nausea. Many adverse effects, including chest pain, hyperhidrosis, headache, dyspnea, and constipation, are more common in Iraqi records than in internationally known instances. Other side effects, such as vomiting, hallucination, vertigo, respiratory depression, and chills, were found to be milder than previously reported. There were no deaths in any of the instances that were recorded during this time period. Conclusion: The number of reported tramadol-induced adverse events has fallen significantly, which can be attributed to the ministry of health restricting tramadol dispensing and enabling public hospitals to only dispense it under medical monitoring.
  • New Targets for Drug Therapy in Type 2 Diabetes Mellitus
    Samer Shukur Mohammed, Asmaa Saleem Muhammed, Amina Saleem Muhammed
    Al Rafidain Journal of Medical Sciences, 2021
    The prevalence of type 2 diabetes mellitus (T2DM) has been increasing at an alarming rate. With an increased understanding of the pathophysiology of T2DM, various new therapeutic options have been developed and evaluated to bind different key targets in T2DM. The discovery of novel therapies through many approaches such as unprecedented drug combinations, modified drug molecules, and improved delivery systems can nullify some of the undesirable side effects of traditional agents, in addition to enhancing their effectiveness. Newer drug targets such as protein kinase B (Akt/PKB), AMP-activated protein kinase (AMPK), sirtuin (SIRT), and others are novel approaches that act via different mechanisms and possibly treating T2DMof distinct variations and etiologies. Other therapies such as end barrier, gene therapy, and stem cell technology utilize advanced techniques to treat T2DM, and the potential of these therapies is still not well explored. Molecular targets in T2DM are also extensively studied as they could target the defects at the molecular level. In this regard, antibody therapies and vaccinations are also developed against T2DM; however, the ongoing clinical trials are scanty, and the developmental progress is slower. There are many therapies designed to cure T2DM, each of them has its advantages and disadvantages. The preference for the treatment plan usually depends on the health status of the patient and the treatment goal. To consider an ideal treatment option, one should worry about many factors. These include patient compliance, drug efficacy and potency, bioavailability, and other pharmacological and non-pharmacological properties among others.
  • Interaction between sleep problems, stimulation drink, and academic performance among students in Baghdad, Iraq
    International Journal of Drug Delivery Technology, 2021
  • Migraine headache and gender differences of Bagdad city population/Iraq
    W. Mustafa, Samer Shukur Mohammed, Zainab Ali Naser
    Indian Journal of Forensic Medicine and Toxicology, 2021
  • Associated factors of adulthood overweight/obesity among pharmacy department students in Al-Rafidain University College / Iraq
    Samer Shukur Mohammed, W. Mustafa
    Indian Journal of Forensic Medicine and Toxicology, 2020
  • Prevalence of cigarette smoking phenomenon in iraqi university students and factors affecting its cessation an observational epidemiologic study
    W. Mustafa, Samer Shukur Mohammed
    Systematic Reviews in Pharmacy, 2020
  • Effects of a combination therapy with atorvastatin and metformin on the glycemic control and adiposity indices in newly diagnosed overweight patients with type 2 diabetes mellitus: A pilot study
    Samer Shukur Mohammed, Wael Waleed Mustafa, Saad Abdulrahman Hussain
    Asian Journal of Pharmaceutical and Clinical Research, 2018

RECENT SCHOLAR PUBLICATIONS

  • Empower Future Professionals: Integrate Pharmacovigilance Education in Formal Pharmaceutical Curricula for Safer Public Health: Cross Sectional Study
    S Mohammed
    DRUG SAFETY 48 (12) , 2025
    2025
  • Development and Assessment of a Self-Nanoemulsifying Drug Delivery System Containing Bilastine: An Effective Strategy to Improve Dissolution
    IK Abbas, AA Abdulqader, AA Hussein, SA Jaber, SS Mohammed
    Al-Rafidain Journal of Medical Sciences 9 (2), 36-45 , 2025
    2025
  • LIFESTYLE VS PHARMACOLOGICAL INTERVENTIONS FOR GLYCEMIC CONTROL IN TYPE 2 DIABETES
    ATO Mutasim Mohammad Rashad Hammoudeh, Ibrahim Jamal Husni Akasheh, Samer ...
    Acta bio-medica: Atenei Parmensis 61 (1) , 2025
    2025
  • The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities’ regulations
    SS Mohammed
    International Journal of Risk & Safety in Medicine, 09246479251412662 , 2025
    2025
  • Knowledge and practice of undergraduate medical students regarding self-medication: A cross-sectional survey in Baghdad, Iraq
    S Mohammed, W Mustafa
    Iraqi national Journal of Medicine 7 (2), 192-8 , 2025
    2025
  • Screening of FDA-approved Drugs against Protein Thymidine Kinase 2 Using Machine Learning Method Validated Applying Molecular Dynamics and Free Energy Landscape Calculation
    HN Sameer, SS Mohammed, AI Oraibi, M Al-Ibadah, HA Al-Hussainy
    Letters in Drug Design & Discovery 21 (18), 4278-4292 , 2024
    2024
  • A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes
    MY Zamanian, M Golmohammadi, B Abdullaev, MO Garcia, AAA Alazbjee, ...
    Cell Biochemistry and Function 42 (3), e4011 , 2024
    2024
    Citations: 15
  • Knowledge and practice of Iraqi community pharmacists on national adverse events reporting and review of the constraints of drug safety reporting
    SS Mohammed, WW Musatafa, MM Younus
    Journal of Pharmacovigilance and Drug Research 4 (4), 24-30 , 2023
    2023
  • Effects of lycopene as monotherapy or combined with clobetasol on spleen index and inflammatory markers in mouse model of imiquimod-induced psoriasis
    SS Mohammed, WW Mustafa
    Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219) 4, 86-91 , 2023
    2023
    Citations: 4
  • Evaluation Lycopene effect as a monotherapy and add on to Clobetasol on Spleen inflammatory biomarkers and spleen index in IMQ induced psoriasis like inflammation in mice
    SS Mohammed, WW Mustafa
    2023
    Citations: 1
  • Interaction between sleep problems, stimulation drink, and academic performance among students in Baghdad, Iraq
    SS Mohammed, WW Mustafa
    Age 24, 1-2 , 2023
    2023
    Citations: 2
  • Experimental Investigation on the Oral and Topical Application of Aloe vera in Wound Care
    WW Mustafa, SS Moahammed
    J. Pharm. Neg. Res 13, 442-450 , 2022
    2022
    Citations: 2
  • Prevalence of Dietary Supplements Use among College Students in Iraq
    WW Mustafa, SS Mohammed, MM Salih, ZT Muhsin, RM Muhsin
    Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219) 3, 36-40 , 2022
    2022
    Citations: 1
  • Consequences of Restricting Tramadol Dispensing in Iraqi Private Healthcare Facilities
    SS Mohammed, WW Mustafa, MM Younus
    Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219) 2, 28-31 , 2022
    2022
  • Anti-inflammatory effects of topically applied azilsartan in a mouse model of imiquimod-induced psoriasis
    SS Mohammed, HM Kadhim, IM AL-Sudani, WW Musatafa
    Int J Drug Deliv Technol 12, 1249-1255 , 2022
    2022
    Citations: 21
  • Impact of Tramadol Restriction Use in Iraq Health Sectors on Adverse Events Reports
    S Mohammed, WW Mustafa, M Younis
    Drug Safety 44 (12), 1427-1428 , 2021
    2021
  • New targets for drug therapy in type 2 diabetes mellitus
    SS Mohammed, AS Muhammed, AS Muhammed
    Al-Rafidain J Med Sci 1, 42-48 , 2021
    2021
    Citations: 2
  • Migraine Headache and Gender Differences of Bagdad City Population/ Iraq
    SSM Wael Waleed Mustafa
    Indian Journal of Forensic Medicine and Toxicology 15 (1), 1787 , 2021
    2021
    Citations: 2
  • Associated Factors of Adulthood Overweight/Obesity among Pharmacy Department Students in Al-Rafidain university College/Iraq
    SS Mohammed, WW Mustafa
    Indian Journal of Forensic Medicine & Toxicology 14 (4), 1652-1658 , 2020
    2020
  • Association of visceral adiposity index, lipid profile, and serum leptin with glucose intolerance risks in Iraqi obese patients: A cross-sectional study
    WW Mustafa, SS Moahammed, WM Al-Jewari, HS Abdulrahman, ...
    Journal of Pharmacy and Bioallied Sciences 12 (4), 468-474 , 2020
    2020
    Citations: 7

MOST CITED SCHOLAR PUBLICATIONS

  • Anti-inflammatory effects of topically applied azilsartan in a mouse model of imiquimod-induced psoriasis
    SS Mohammed, HM Kadhim, IM AL-Sudani, WW Musatafa
    Int J Drug Deliv Technol 12, 1249-1255 , 2022
    2022.0
    Citations: 21
  • Study the Topical Effect of Six Days Use of Different Lycopene Doses on Imiquimod-Induce Psoriasis-Like Skin Inflammation in Mice
    SS Mohammed, HM Kadhim, IM Al-Sudani, WW Musatafa
    Citations: 20
  • A narrative review on therapeutic potential of naringenin in colorectal cancer: Focusing on molecular and biochemical processes
    MY Zamanian, M Golmohammadi, B Abdullaev, MO Garcia, AAA Alazbjee, ...
    Cell Biochemistry and Function 42 (3), e4011 , 2024
    2024.0
    Citations: 15
  • Association of visceral adiposity index, lipid profile, and serum leptin with glucose intolerance risks in Iraqi obese patients: A cross-sectional study
    WW Mustafa, SS Moahammed, WM Al-Jewari, HS Abdulrahman, ...
    Journal of Pharmacy and Bioallied Sciences 12 (4), 468-474 , 2020
    2020.0
    Citations: 7
  • Effects of lycopene as monotherapy or combined with clobetasol on spleen index and inflammatory markers in mouse model of imiquimod-induced psoriasis
    SS Mohammed, WW Mustafa
    Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219) 4, 86-91 , 2023
    2023.0
    Citations: 4
  • The anti-inflammatory activity of Azilsartan in animal models of experimentallyinduced chronic and granulomatous inflammations
    WW Mustafa, S Shukor, SA Husain, NMA Mahmood
    International Journal of Research in Pharmaceutical Sciences 9 (4), 1162-1168 , 2018
    2018.0
    Citations: 3
  • Interaction between sleep problems, stimulation drink, and academic performance among students in Baghdad, Iraq
    SS Mohammed, WW Mustafa
    Age 24, 1-2 , 2023
    2023.0
    Citations: 2
  • Experimental Investigation on the Oral and Topical Application of Aloe vera in Wound Care
    WW Mustafa, SS Moahammed
    J. Pharm. Neg. Res 13, 442-450 , 2022
    2022.0
    Citations: 2
  • New targets for drug therapy in type 2 diabetes mellitus
    SS Mohammed, AS Muhammed, AS Muhammed
    Al-Rafidain J Med Sci 1, 42-48 , 2021
    2021.0
    Citations: 2
  • Migraine Headache and Gender Differences of Bagdad City Population/ Iraq
    SSM Wael Waleed Mustafa
    Indian Journal of Forensic Medicine and Toxicology 15 (1), 1787 , 2021
    2021.0
    Citations: 2
  • Effect of silibinin on the sensitivity of Enterobacter cloacae resistant isolate to gentamicin: In vitro study
    WM Al-Jewari, ZO Ibraheem, SS Mohammed, WW Mustafa, SA Hussain
    Asian J. Microbiol. Biotechnol. Environ. Sci 22, 248-253 , 2020
    2020.0
    Citations: 2
  • Evaluation Lycopene effect as a monotherapy and add on to Clobetasol on Spleen inflammatory biomarkers and spleen index in IMQ induced psoriasis like inflammation in mice
    SS Mohammed, WW Mustafa
    2023.0
    Citations: 1
  • Prevalence of Dietary Supplements Use among College Students in Iraq
    WW Mustafa, SS Mohammed, MM Salih, ZT Muhsin, RM Muhsin
    Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219) 3, 36-40 , 2022
    2022.0
    Citations: 1
  • EFFECTS OF A COMBINATION THERAPY WITH ATORVASTATIN AND METFORMIN ON THE GLYCEMIC CONTROL AND ADIPOSITY INDICES IN NEWLY DIAGNOSED OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES …
    SS MOHAMMED, WW MUSTAFA, SA HUSSAIN
    Asian J Pharm Clin Res 11 (12), 209-213 , 2018
    2018.0
    Citations: 1
  • Empower Future Professionals: Integrate Pharmacovigilance Education in Formal Pharmaceutical Curricula for Safer Public Health: Cross Sectional Study
    S Mohammed
    DRUG SAFETY 48 (12) , 2025
    2025.0
  • Development and Assessment of a Self-Nanoemulsifying Drug Delivery System Containing Bilastine: An Effective Strategy to Improve Dissolution
    IK Abbas, AA Abdulqader, AA Hussein, SA Jaber, SS Mohammed
    Al-Rafidain Journal of Medical Sciences 9 (2), 36-45 , 2025
    2025.0
  • LIFESTYLE VS PHARMACOLOGICAL INTERVENTIONS FOR GLYCEMIC CONTROL IN TYPE 2 DIABETES
    ATO Mutasim Mohammad Rashad Hammoudeh, Ibrahim Jamal Husni Akasheh, Samer ...
    Acta bio-medica: Atenei Parmensis 61 (1) , 2025
    2025.0
  • The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities’ regulations
    SS Mohammed
    International Journal of Risk & Safety in Medicine, 09246479251412662 , 2025
    2025.0
  • Knowledge and practice of undergraduate medical students regarding self-medication: A cross-sectional survey in Baghdad, Iraq
    S Mohammed, W Mustafa
    Iraqi national Journal of Medicine 7 (2), 192-8 , 2025
    2025.0
  • Screening of FDA-approved Drugs against Protein Thymidine Kinase 2 Using Machine Learning Method Validated Applying Molecular Dynamics and Free Energy Landscape Calculation
    HN Sameer, SS Mohammed, AI Oraibi, M Al-Ibadah, HA Al-Hussainy
    Letters in Drug Design & Discovery 21 (18), 4278-4292 , 2024
    2024.0